Cefaloridine is an antibiotic that is used to treat various bacterial infections, including urinary tract infections, bronchitis, and pneumonia. It belongs to a class of drugs called cephalosporins. Cefaloridine works by killing bacteria or preventing their growth. It is usually taken orally as tablets or capsules, but can also be given intravenously. Common side effects of cefaloridine include nausea, vomiting, diarrhea, and rash.
Cefaloridine: A Discontinued First-Generation Cephalosporin Antibiotic
Cefaloridine, also known by the brand name Cecloridine, was a first-generation cephalosporin antibiotic. While no longer commercially available due to safety concerns, it's important to note its historical significance and potential reasons for its discontinuation.
Mechanism of Action:
Similar to other cephalosporins, Cefaloridine worked by interfering with bacterial cell wall synthesis. It bound to penicillin-binding proteins (PBPs) in the bacterial cell wall, preventing them from forming the cross-links necessary for strength and rigidity. This weakened cell wall ultimately led to the death of the bacteria.
Historical Use:
- Cefaloridine was introduced in the 1960s and was used to treat a broad spectrum of bacterial infections, including:
- Skin and soft tissue infections
- Respiratory tract infections
- Urinary tract infections
- Bone infections
Discontinuation:
- Cefaloridine was withdrawn from the market in many countries, including the United States and the United Kingdom, in the 1970s and 1980s.
- The primary reason for its discontinuation was the emergence of safer and more effective cephalosporin antibiotics with broader spectrums and fewer side effects.
- Additionally, Cefaloridine was associated with a higher risk of serious side effects, including:
- Nephrotoxicity (kidney damage)
- Neurotoxicity (nervous system damage)